Manifest: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos, Francesco Passamonti, Raajit K Rampal, Adam J Mead, Gabriella Hobbs, Joseph M Scandura, Moshe Talpaz, Nikki Granacher, Tim C P Somervaille, Ronald Hoffman, Marielle J Wondergem, Mohamed E Salama, Gozde Colak, Jike Cui, Jean-Jacques Kiladjian, Alessandro M VannucchiSrdan Verstovsek, Natalia Curto-García, Claire Harrison, Vikas Gupta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Manifest: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science